Skip to main content
Cervixel logoCervixel
Preorder

Preorder RapidCan.

RapidCan is currently in development and is expected to reach market within approximately two years, subject to regulatory review and clinical study completion. Preorder gives early supporters priority allocation, preferred pricing, and an opportunity to help fund cervical cancer screening capacity ahead of launch.

Audience

Built for organisations placing screening capacity at scale.

  • Private clinics

    Independent clinical practices and screening providers placing tests in routine cervical cancer screening pathways.

  • Distributors

    Diagnostic distributors placing RapidCan into clinical and community networks across geographies.

  • Charities & health organisations

    Non-profits and public-health initiatives funding screening capacity in under-served regions.

  • Governments

    Ministries of health, regional authorities, and public screening programmes procuring at population scale.

Why preorder

Priority allocation. Preferred pricing. Direct support for early deployment.

Preorder customers receive priority allocation when RapidCan begins shipping. Capacity in the first production runs is limited; organisations who preorder are queued before general availability opens.

Preorder pricing is offered at up to 60% below post-launch list price, with tiering tied to volume. Final pricing is confirmed when your organisation is contacted, and no payment is captured until you’ve reviewed the documentation your jurisdiction requires.

Preorder commitments help Cervixel plan production, regulatory documentation, and clinical-validation throughput against real demand from organisations who are ready to deploy screening at scale.

Packages

Choose a starting volume.

  • 100 units

    Pilot deployments, single-site validation, early clinical evaluation.

  • 1,000 units

    Small networks, regional programmes, mid-size distributors entering screening.

  • 5,000 units

    National screening programmes, large distributor placements, mid-size health systems.

  • 10,000 units

    Population-scale deployments, government procurement, multi-region distribution.

Volumes above 10,000 units are supported on the same preorder pathway — select 10,000 in the form below and note your target volume in the message.

Register interest

Tell us about your preorder.

We’ll contact you within five business days to confirm pricing, allocation, and the documentation your jurisdiction requires. No payment is captured here.

required

Your details are used only to respond to your preorder enquiry. See our privacy policy for how we handle data submitted through this form.

Questions first?

Talk to us before you preorder.

If your organisation is still scoping volume, pricing, or regulatory requirements, the team can answer questions before you submit a preorder enquiry.